GT201200336BA - Composición farmacéutica que comprende drospirenona y kit anticonceptivo (solicitud divisional no. 2) - Google Patents

Composición farmacéutica que comprende drospirenona y kit anticonceptivo (solicitud divisional no. 2)

Info

Publication number
GT201200336BA
GT201200336BA GT201200336BL GT201200336L GT201200336BA GT 201200336B A GT201200336B A GT 201200336BA GT 201200336B L GT201200336B L GT 201200336BL GT 201200336 L GT201200336 L GT 201200336L GT 201200336B A GT201200336B A GT 201200336BA
Authority
GT
Guatemala
Prior art keywords
conceptive
pharmaceutical composition
composition including
kit
drospirenone
Prior art date
Application number
GT201200336BL
Other languages
English (en)
Spanish (es)
Inventor
Velada Jose
Drouin Dominique
Perrin Philippe
Original Assignee
Laboratorios Leon Farma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48802149&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT201200336B(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratorios Leon Farma Sa filed Critical Laboratorios Leon Farma Sa
Publication of GT201200336BA publication Critical patent/GT201200336BA/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GT201200336BL 2010-06-29 2012-12-12 Composición farmacéutica que comprende drospirenona y kit anticonceptivo (solicitud divisional no. 2) GT201200336BA (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10305708 2010-06-29
US36839610P 2010-07-28 2010-07-28

Publications (1)

Publication Number Publication Date
GT201200336BA true GT201200336BA (es) 2017-10-23

Family

ID=48802149

Family Applications (3)

Application Number Title Priority Date Filing Date
GT201200336AK GT201200336AA (es) 2010-06-29 2012-12-12 Composición farmacéutica que comprende drospirenona y kit anticonceptivo (solicitud divisional no. 1)
GT201200336BL GT201200336BA (es) 2010-06-29 2012-12-12 Composición farmacéutica que comprende drospirenona y kit anticonceptivo (solicitud divisional no. 2)
GT201200336A GT201200336A (es) 2010-06-29 2012-12-12 Composiciòn farmacèutica que comprende drospirenona y kit anticonceptivo

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GT201200336AK GT201200336AA (es) 2010-06-29 2012-12-12 Composición farmacéutica que comprende drospirenona y kit anticonceptivo (solicitud divisional no. 1)

Family Applications After (1)

Application Number Title Priority Date Filing Date
GT201200336A GT201200336A (es) 2010-06-29 2012-12-12 Composiciòn farmacèutica que comprende drospirenona y kit anticonceptivo

Country Status (14)

Country Link
KR (1) KR102210982B1 (hu)
BR (1) BR122019008317A2 (hu)
CL (1) CL2012003685A1 (hu)
CO (1) CO6640328A2 (hu)
DK (1) DK2588114T3 (hu)
EC (3) ECSP12012359A (hu)
ES (1) ES2777886T3 (hu)
GT (3) GT201200336AA (hu)
HR (1) HRP20200155T1 (hu)
HU (1) HUE047689T2 (hu)
LT (2) LT2588114T (hu)
MX (3) MX364971B (hu)
PT (1) PT2588114T (hu)
ZA (1) ZA201209743B (hu)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009138224A1 (en) * 2008-05-14 2009-11-19 Helm Ag Pharmaceutical composition comprising drospirenone

Also Published As

Publication number Publication date
ECSP15032911A (es) 2016-01-29
ECSP15032906A (es) 2016-01-29
MX2012014629A (es) 2013-05-06
PT2588114T (pt) 2020-02-20
ZA201209743B (en) 2014-03-26
LTPA2021523I1 (hu) 2021-11-10
KR20190073598A (ko) 2019-06-26
HUE047689T2 (hu) 2020-05-28
CO6640328A2 (es) 2013-03-22
ECSP12012359A (es) 2013-03-28
MX364971B (es) 2019-05-16
CL2012003685A1 (es) 2013-07-05
GT201200336A (es) 2014-01-14
MX339952B (es) 2016-06-20
KR102210982B1 (ko) 2021-02-02
GT201200336AA (es) 2017-10-23
DK2588114T3 (da) 2020-02-17
HRP20200155T1 (hr) 2020-05-01
MX2019004393A (es) 2019-09-09
ES2777886T3 (es) 2020-08-06
BR122019008317A2 (pt) 2020-09-29
LT2588114T (lt) 2020-02-25

Similar Documents

Publication Publication Date Title
AR081670A1 (es) Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
CR20110216A (es) Derivados de ácido 1-amino-2-ciclobutiletilborónico
GT201000023A (es) Nuevos derivados de 6-trialzolopiridacina-sulfanil benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion principalmente como inhibidores de met.
UY32626A (es) Inhibidores de beta-lactamasa
UY31561A1 (es) Azolilmetiloxiranos, su uso y agentes que los contienen
MA32369B1 (fr) Composes de benzene sulfonamide thiazole et oxazole
HN2012001162A (es) Triazolopiridinas
CL2012001911A1 (es) Compuestos derivados de fumarato; composicion farmaceutica que los comprende; y su uso en el tratamiento de una enfermedad inflamatoria o neurodegenerativa.
CR20140216A (es) 5,7-imidazo[1,2-c]pirimidinas sustituidas
CL2008003284A1 (es) Compuestos derivados de 4-bencilamino-1-carboxiacil-piridina, inhibidores cetp; composicion farmaceutica que los comprende; combinacion farmaceutica; y uso en el tratamiento de enfermedades metabolicas, ateroesclerosis y cardiovasculares, entre otras.
ECSP10010129A (es) Inhibidores de quinasas símil polo
HN2008001393A (es) Derivados de 1,2,4,5- tetrahidro -3h- benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
NI200800227A (es) Acidos 1,3-dioxano carboxilicos
HN2008001521A (es) Dimeros de derivados de artemisinina, su preparacion y su aplicacion en terapeutica
CR10654A (es) Agentes que comprenden compuestos marcados con 18f y metodos relacionados
CO6420349A2 (es) Novedoso derivados de compuestos esteroidal[3,2-c]pirazoles con actividad glucocorticoide
AR063027A1 (es) Derivados de sulfonamida
HN2011000404A (es) Derivados de enfumafungina y composicion comprendiendo los mismos
AR077429A1 (es) Compuestos hidroxiasenapina sus derivados y composiciones farmaceuticas que comprenden los mismos
ECSP109874A (es) Nuevos compuestos 892
GT201200336BA (es) Composición farmacéutica que comprende drospirenona y kit anticonceptivo (solicitud divisional no. 2)
ECSP099328A (es) Análogos de pirazol
DK2155886T3 (da) Kosmetisk anvendelse af tyrosinaseinhibitorer
ECSP10010292A (es) Nuevos derivados de ácido 2-mercaptociclopentanocarboxílico, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
CR20120109A (es) Nuevos derivados dihidro-oxazolobenzodiazepinonas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen